VOLUMATIC LIMITED

Financial Health Assessment: Volumatic Limited

1. Financial Health Score: B+ (Good Structural Health)

Explanation: Based on the available metadata, Volumatic Limited presents a strong outward appearance of administrative health and corporate stability. The company has a long history of survival, maintains excellent compliance vitals (no overdue filings), and operates at a substantial "Medium" size. However, a definitive "A" grade cannot be issued without a detailed examination of the internal financial blood work (profit & loss, cash flow, and balance sheet metrics), which is not present in the current dataset.

2. Key Vital Signs

• Corporate Longevity (Incorporation Date): 1972-09-01. This patient is over 50 years old. In the business world, surviving multiple economic cycles indicates exceptional genetic resilience and adaptability. This is a very healthy sign of a robust immune system against market downturns.
• Compliance Pulse (Filing Status): NO overdue filings. The company’s accounts and confirmation statements are completely up to date. This indicates a healthy, regular heartbeat with no administrative arrhythmias. The business is paying attention to its regulatory hygiene.
• Size & Stature (Accounts Category): Medium. To qualify as a medium-sized entity, the company must meet at least two of three thresholds: turnover ≤ £36M, balance sheet ≤ £18M, and ≤ 250 employees. This tells us the business has grown to a healthy adult size with significant operational scale in the manufacturing sector.
• Ownership DNA (PSC): Volumatic Holdings Limited. The company is a subsidiary of a holding company, which owns more than 75% of shares and voting rights. This is a common corporate structure, meaning the ultimate financial nourishment and risk may be tied to the parent company's health.
• Share Capital: £1,000. A relatively low issued share capital for a medium-sized business. This suggests the company is lean on permanent equity capital, likely relying on retained profits (P&L reserves) or parent company funding to finance its operations.
• Organ Function (Board of Directors): 6 Current Directors + 1 Secretary. A well-staffed executive function. However, there has been a recent change in the board's composition with the resignation of Director Michael Adam Severs in November 2025, which warrants monitoring.

3. Diagnosis

Outwardly Stable, but Internal Blood Work Required. Based on the external vital signs, Volumatic Limited is not exhibiting any immediate symptoms of financial distress or administrative neglect. The company is active, compliant, and well-established within its niche (Manufacture of office machinery/equipment, specifically cash handling solutions).

The recent resignation of a director in late 2025 is a minor symptom to monitor—while often a natural corporate occurrence (like a minor skin rash), sudden board changes can occasionally signal deeper internal disagreements or strategic shifts.

The primary limitation of this examination is the absence of quantitative financial metrics (turnover, net assets, cash position). Because the company is classified as "Medium", it files abbreviated accounts, meaning the full financial circulatory system (cash flow, detailed P&L) is not immediately visible without accessing the parent company's consolidated group accounts. The low share capital (£1,000) paired with a medium-sized operation suggests the company runs on a lean capital base, making the health of its working capital (current assets minus current liabilities) the critical factor in keeping the business from needing emergency resuscitation.

4. Recommendations

• Monitor the Board Changes: Keep a close eye on the board of directors following the recent resignation. Ensure no further unexpected departures occur, which could indicate a systemic issue within the corporate governance.
• Review the Parent Company's Health: Since Volumatic Holdings Limited holds the controlling interest, a true diagnosis requires examining the parent company's consolidated accounts. The subsidiary's health is intrinsically linked to the parent's financial life support.
• Maintain Compliance Hygiene: Continue the excellent track record of timely filings. Late filings are often the first fever symptom of underlying cash flow or operational problems.
• Assess Working Capital Resilience: Internally, management should ensure that working capital levels remain robust. With a lean share capital base, the company must ensure its current assets (cash, debtors, stock) are healthy enough to cover its current liabilities (debts due within one year) without relying on emergency injections from the holding company.